Mood stabilisers plus risperidone or placebo in the treatment of acute mania: International, double-blind, randomised controlled trial

Yatham, Laksami N., Grossman, Fred, Augustyns, Ilse, Vieta, Eduard, Ravindran, Arun·2003·British Journal of Psychiatry
DOI 10.1192/bjp.182.2.141

Cited by (248)

Items 101–200 of 248

  1. The armamentarium of treatments for bipolar disorder: a review of the literature
    David A. Cousins, Allan Hunter Young · 2006 · The International Journal of Neuropsychopharmacology
  2. Is Anticonvulsant Treatment of Mania a Class Effect? Data from Randomized Clinical Trials
    Adriane Ribeiro Rosa, Konstantinos Ν. Fountoulakis, Melina Siamouli, Xénia Gonda, Eduard Vieta · 2009 · CNS Neuroscience & Therapeutics
  3. The Use of Antiepileptic Drugs in Bipolar Disorders: A Review Based on Evidence From Controlled Trials
    Richard H. Weisler, Andrew J. Cutler, James C. Ballenger, Robert M. Post, Terence A. Ketter · 2006 · CNS Spectrums
  4. Acute and continuation risperidone monotherapy in mania
    Eduard Vieta, Esteve Brugué, José Manuel Goikolea, José Sánchez‐Moreno, María Reinares, Mercé Comes, Francesc Colom, Anabel Martínez‐Arán, Antoni Benabarre, Carla Torrent · 2004 · Human Psychopharmacology Clinical and Experimental
  5. Atypical Antipsychotics for the Treatment of Bipolar Disorder
    Salvatore Gentile · 2007 · CNS Drugs
  6. Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management
    Chue, Pierre, Kovacs, Christopher S · 2003 · Bipolar Disorders
  7. Risperidone in the management of agitation and aggression associated with psychiatric disorders
    Peter Paul De Deyn, Jan K. Buitelaar · 2006 · European Psychiatry
  8. Adjunctive treatment of acute mania: a clinical overview
    G. S. Sachs, Erica E. Gardner-Schuster · 2007 · Acta Psychiatrica Scandinavica
  9. Atypical mood stabilizers: a ‘typical’ role for atypical antipsychotics
    Gin Singh Malhi, M. Berk, Michel Bourin, Belinda Ivanovski, Seetal Dodd, Jim Lagopoulos, Philip Bowden Mitchell · 2005 · Acta Psychiatrica Scandinavica
  10. Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of mania
    Lakshmi N. Yatham, Carin E. Binder, Vivek Kusumakar, Rosanna Riccardelli · 2004 · International Clinical Psychopharmacology
  11. Novel antipsychotics in bipolar and schizoaffective mania
    G. J. R. Mensink, Cees J. Slooff · 2004 · Acta Psychiatrica Scandinavica
  12. The Pharmacological Treatment of Bipolar Disorder: The Question of Modern Advances
    Jack Hirschowitz, Alexander Kolevzon, Amir Garakani · 2010 · Harvard Review of Psychiatry
  13. Bipolar disorder
    Gérard Emilien, Lucia Septien, Claudine Brisard, Emmanuelle Corruble, Michel Bourin · 2007 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  14. Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission
    Terence A. Ketter, Ofer Agid, Shitij Kapur, Antony D Loebel, CYNTHIA O. SIU, Steven J. Romano · 2009 · Journal of Psychiatric Research
  15. Pharmacokinetic Drug-Drug Interactions of Mood Stabilizers and Risperidone in Patients Under Combined Treatment
    Georgios Schoretsanitis, Ekkehard Haen, Gerhard Gründer, Benedikt Stegmann, Koen R.J. Schruers, Christoph Hiemke, Sarah Edith Lammertz, Michael Paulzen · 2016 · Journal of Clinical Psychopharmacology
  16. Toward Convergence in the Medication Treatment of Bipolar Disorder and Schizophrenia
    Leslie Citrome, Joseph F. Goldberg, Stephen M. Stahl · 2005 · Harvard Review of Psychiatry
  17. Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
    Roy H. Perlis · 2007 · PubMed
  18. Treatment of bipolar mania with atypical antipsychotics
    KN Roy Chengappa, Trisha M Suppes, Michael Berk · 2004 · Expert Review of Neurotherapeutics
  19. New medication treatment options for bipolar disorders
    Terence A. Ketter, Po W. Wang, Cecylia Nowakowska, Wendy Marsh · 2004 · Acta Psychiatrica Scandinavica
  20. Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis
    Britta Galling, Maryam A Garcia, Uzoma Osuchukwu, Katsuhiko Hagi, Christoph Ulrich Correll · 2015 · Expert Opinion on Drug Safety
  21. Effectiveness of lamotrigine in bipolar disorder in a clinical setting
    Terence A. Ketter, John O. Brooks, Jennifer C. Hoblyn, Laurel M. Champion, Jennifer Y. Nam, Jenifer L. Culver, Wendy Marsh, Julie C. Bonner · 2008 · Journal of Psychiatric Research
  22. Critical Issues on the Use of Network Meta-analysis in Psychiatry
    Ayşegül Yıldız, Eduard Vieta, Christoph Ulrich Correll, Mateusz Nikodem, Ross J. Baldessarini · 2014 · Harvard Review of Psychiatry
  23. Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study
    Won‐Myong Bahk, Young-Chul Shin, Jong‐Min Woo, Bo-Hyun Yoon, Jung-Seo Lee, Duk‐In Jon, Sang‐Keun Chung, Sung‐Ku Choi, In‐Ho Paik, Chi‐Un Pae · 2004 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  24. Placebo‐level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania
    Henry A. Nasrallah, Martin Brecher, Björn Paulsson · 2006 · Bipolar Disorders
  25. Bipolar II and the bipolar spectrum
    Peter Skeppar, Rolf Adolfsson · 2006 · Nordic Journal of Psychiatry
  26. Antipsychotics in the Treatment of Bipolar Disorder
    Jaskaran B. Singh, Guang Chen, Carla M. Canuso · 2012 · Handbook of experimental pharmacology
  27. Anticonvulsivantes e antipsicóticos no tratamento do transtorno bipolar
    Ricardo Alberto Moreno, Doris Hupfeld Moreno, Márcia Britto de Macedo Soares, Roberto Ratzke · 2004 · Brazilian Journal of Psychiatry
  28. RETRACTED: Synthesis and application of conductive polymeric ionic liquid/Ni nanocomposite to construct a nanostructure based electrochemical sensor for determination of risperidone and methylphenidate
    Elaheh Molaakbari, Ali Mostafavi, Zeinab Tohidiyan, Hadi Beitollahi · 2017 · Journal of Electroanalytical Chemistry · Retracted
  29. Effective maintenance treatment—breaking the cycle of bipolar disorder
    Guy M. Goodwin, Eduard Vieta · 2005 · European Psychiatry
  30. Methodological differences between pharmacological treatment guidelines for bipolar disorder: what to do for the clinicians?
    Ludovic Samalin, Sébastien Guillaume, Philippe Courtet, Mocrane Abbar, Sylvie Lancrenon, Pierre‐Michel Llorca · 2012 · Comprehensive Psychiatry
  31. False-Negative Studies May Systematically Contaminate the Literature on the Effects of Inducers in Neuropsychopharmacology. Part I
    José de León · 2014 · Journal of Clinical Psychopharmacology
  32. Risperidone in acute and long-term therapy of schizophrenia—a clinical profile
    Frank–Gerald Pajonk · 2003 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  33. Long-acting risperidone: a review of its role in the treatment of bipolar disorder
    David E. Kemp, Fatih Canan, Benjamin I. Goldstein, Roger S. McIntyre · 2009 · Advances in Therapy
  34. Treatment-refractory bipolar disorder: classification to aid in clinical management
    Prashant Gajwani · 2009 · Expert Opinion on Pharmacotherapy
  35. Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?
    Konstantinos Ν. Fountoulakis, Xénia Gonda, Eduard Vieta, Zoltán Rihmer · 2011 · Annals of General Psychiatry
  36. Stabilization Beyond Mood: Stabilizing Patients With Bipolar Disorder in the Various Phases of Life
    Alessio Simonetti, Alexia Emilia Koukopoulos, Georgios Demetrios Kotzalidis, Delfina Janiri, Lavinia De Chiara, Luigi Janiri, Gabriele Sani · 2020 · Frontiers in Psychiatry
  37. False-Negative Studies May Systematically Contaminate the Literature on the Effects of Inducers in Neuropsychopharmacology
    José de León · 2014 · Journal of Clinical Psychopharmacology
  38. Behavioral Neurobiology of Bipolar Disorder and its Treatment
    Husseini K. Manji, Carlos A. Zarate · 2010 · Current topics in behavioral neurosciences
  39. An overview of pharmacotherapy for bipolar I disorder
    Anne Morsel, Manuel Morrens, Bernard Sabbe · 2018 · Expert Opinion on Pharmacotherapy
  40. Rehospitalization rates of patients with bipolar disorder discharged on a mood stabilizer versus a mood stabilizer plus an atypical or typical antipsychotic
    Nick C. Patel, M. Lynn Crismon, Michael Pondrom · 2005 · The Journal of Behavioral Health Services & Research
  41. Mood Stabilizers and Antipsychotics for Acute Mania: Systematic Review and Meta-Analysis of Augmentation Therapy vs Monotherapy From the Perspective of Time to the Onset of Treatment Effects
    Aran Tajika, Hikaru Hori, Jun‐ichi Iga, Yosuke Koshikawa, Haruhiko Ogata, Yusuke Ogawa, Koichiro Watanabe, Tadafumi Kato, Koji Matsuo, Masaki Kato · 2022 · The International Journal of Neuropsychopharmacology
  42. The Contemporary Face of Bipolar Illness:Complex Diagnostic and Therapeutic Challenges
    Konstantinos Ν. Fountoulakis · 2008 · CNS Spectrums
  43. Risperidone in the treatment of bipolar mania
    Martha Sajatovic, Subramoniam, Madhusoodanan, Matthew A. Fuller · 2006 · Neuropsychiatric Disease and Treatment
  44. Traitement du trouble bipolaire en phase maniaque : synthèse critique des recommandations internationales
    Pierre A. Geoffroy, Frank Bellivier, Chantal Henry · 2014 · L Encéphale
  45. Guideline Watch (November 2005): Practice Guideline for the Treatment of Patients with Bipolar Disorder, 2nd Edition
    Robert M. A. Hirschfeld · 2007 · FOCUS The Journal of Lifelong Learning in Psychiatry
  46. Rank-Based Analyses of Stratified Experiments: Alternatives to the van Elteren Test
    Devan V. Mehrotra, Xiaomin Lu, Xiaoming Li · 2010 · The American Statistician
  47. How Assess Drugs in the Treatment of Acute Bipolar Mania?
    Michel Bourin, Florence Thibaut · 2013 · Frontiers in Pharmacology
  48. A single‐blind, comparative study of zotepine versus haloperidol in combination with a mood stabilizer for patients with moderate‐to‐severe mania
    Hung‐Yu Chan, Shaw‐Hua Jou, Yeong‐Yuh Juang, Ching‐Jui Chang, Jiahn‐Jyh Chen, Chiung‐Hsu Chen, Nan‐Ying Chiu · 2010 · Psychiatry and Clinical Neurosciences
  49. Drug Class Review: Atypical Antipsychotic Drugs
    Marian S. McDonagh, Kim Peterson, Susan Carson, Rochelle Fu, Sujata Thakurta · 2010
  50. Atypical antipsychotics in the treatment of bipolar disorder
    Stephen M. Strakowski, Melissa P. Del Bello, Caleb M. Adler, Paul E. Keck · 2003 · Expert Opinion on Pharmacotherapy
  51. Trial of risperidone in India – concerns
    Sandhya Srinivasan, Shaila Pai, A. Bhan, Amar Jesani, G. Thomas · 2006 · The British Journal of Psychiatry
  52. Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania
    Wen‐Chen Ouyang, Mei‐Chi Hsu, I-Ning Yeh, Chien-Cheng Kuo · 2012 · International Journal of Psychiatry in Clinical Practice
  53. Risperidone in combination with mood stabilizers for acute mania: a multicentre, open study
    Won‐Myong Bahk, Jin‐Sang Yoon, Young-Hoon Kim, Yang-Hyun Lee, Chul Lee, Kwangsoo Kim, Hye-Kyoung Song, Sung‐Ku Choi, Chi‐Un Pae · 2004 · International Clinical Psychopharmacology
  54. Depression symptom ratings in geriatric patients with bipolar mania
    Martha Sajatovic, Rayan Al Jurdi, Ariel G. Gildengers, Rebecca L. Greenberg, Thomas R. TenHave, MARTHA LIVINGSTON BRUCE, Benoit H. Mulsant, Robert C. Young · 2011 · International Journal of Geriatric Psychiatry
  55. Study design and patient characteristics and outcome in acute mania clinical trials
    Gregory Patrick Tarr, Peter Herbison, Sophia Leon de la Barra, Paul Glue · 2011 · Bipolar Disorders
  56. Clinical use of carbamazepine for bipolar disorders
    Po W. Wang, Terence A. Ketter · 2005 · Expert Opinion on Pharmacotherapy
  57. A systematic review of the efficacy and safety of second generation antipsychotics in the treatment of mania
    Roland M. Jones, C. Thompson, István Bitter · 2005 · European Psychiatry
  58. Combination Treatment With Aripiprazole and Valproic Acid for Acute Mania
    Hyun‐Ghang Jeong, Moon‐Soo Lee, Young‐Hoon Ko, Changsu Han, In‐Kwa Jung · 2012 · Clinical Neuropharmacology
  59. Treatment of aggression with risperidone in children and adolescents with bipolar disorder: a case series
    Kirti Saxena, Kiki Chang, Hans Steiner · 2006 · Bipolar Disorders
  60. Risperidone for bipolar disorders
    Martha Sajatovic, Subramoniam Madhusoodanan, Matthew A. Fuller, Lakynetiew Aulakh, Daniel Brian Keaton · 2005 · Expert Review of Neurotherapeutics
  61. Anticonvulsants in Bipolar Disorder
    Vivek Kumar Singh, David J. Muzina, Joseph R. Calabrese · 2005 · Psychiatric Clinics of North America
  62. Recent developments in the treatment of bipolar disorders
    Michael Berk, Seetal Dodd · 2003 · Expert Opinion on Investigational Drugs
  63. Atypical antipsychotics in bipolar disorder: the treatment of mania
    John Cookson · 2008 · Advances in Psychiatric Treatment
  64. Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting
    Terence A. Ketter, John O. Brooks, Jennifer C. Hoblyn, Anne A. Holland, Jennifer Y. Nam, Jenifer L. Culver, Wendy Marsh, Julie C. Bonner · 2010 · Journal of Psychiatric Research
  65. Switching to quetiapine in patients with acute mania who were intolerant to risperidone
    Chi‐Un Pae, Kyong‐Uk Lee, Jung‐Jin Kim, Chang‐Uk Lee, Won‐Myong Bahk, Soo‐Jung Lee, Chul Lee, In‐Ho Paik · 2004 · Human Psychopharmacology Clinical and Experimental
  66. Risperidone Treatment of Bipolar Mania
    Lisa N Nguyen, Sally K. Guthrie · 2006 · Annals of Pharmacotherapy
  67. Risperidone Versus Risperidone Plus Sodium Valproate for Treatment of Bipolar Disorders: A Randomized, Double-Blind Clinical-Trial
    Seyed Mohammad Moosavi, Mahshid Ahmadi, Mani B. Monajemi · 2014 · Global Journal of Health Science
  68. Risperidone adjunctive therapy duration in the maintenance treatment of bipolar I disorder: A post hoc analysis
    Mirjana Valdes, Sara Bertolín, Hong Qian, Hubert Wong, Raymond Wing Moon Lam, Lakshmi N. Yatham · 2019 · Journal of Affective Disorders
  69. Bipolar (Manic Depressive) Disorders
    Rif S. El‐Mallakh, Mark S. Bauer · 2015 · Wiley eBooks
  70. Divalproex sodium in the treatment of adults with bipolar disorder
    Lori L. Davis, Raela B. Williams, Marshall E. Cates · 2004 · Expert Review of Neurotherapeutics
  71. Galactorrhea - side effect of risperidone in combination with depakine chrono in a patient with bipolar disorder.
    Marija Vučić Peitl, Vjekoslav Peitl, Tanja Grahovac, Eudard Pavlović · 2010 · PubMed
  72. Higher than Physician’s Desk Reference (US) doses on atypical antipsychotics
    Paul J. Goodnick · 2005 · Expert Opinion on Drug Safety
  73. Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection
    Pierre‐Michel Llorca, Ludovic Samalin, Charpeaud, Lorabi · 2010 · Patient Preference and Adherence
  74. Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practice
    Diego Novick, Catherine C. Reed, Josep Maria Haro, Ana María González-Pinto, Eléna Perrin, Jaume Aguado, Mauricio F. Tohen · 2010 · International Clinical Psychopharmacology
  75. CYP2D6 pharmacogenetics and risperidone: reflections after 25 years of research.
    J. de Leon, G. Schoretsanitis · 2020 · Pharmacogenomics (London)
  76. Symptomatic Remission in Patients with Bipolar Mania: Results from a Double-Blind, Placebo-Controlled Trial of Risperidone Monotherapy
    Srihari Gopal, John L. Beyer, David C. Steffens, Michelle L. Kramer · 2007 · Progress in Neurotherapeutics and Neuropsychopharmacology
  77. Chapter 49. Treatment of Bipolar Disorder
    Stephen M. Strakowski, Paul E. Keck · 2024 · American Psychiatric Association Publishing eBooks
  78. Pharmacological Treatments for Bipolar Disorder: Present Recommendations and Future Prospects
    Charles L. Bowden · 2010 · Current topics in behavioral neurosciences
  79. The risk of harm in mania and the very early time course of improvement: important but neglected variables in treatment research
    Chittaranjan Andrade · 2004 · Bipolar Disorders
  80. Emerging drugs for bipolar disorder
    Philip Bowden Mitchell, Gin Singh Malhi · 2006 · Expert Opinion on Emerging Drugs
  81. Valproate-Risperidone versus Valproate-Lithium combination in acute mania
    Majid Barekatain, Alimohammad Fatemi, Nasrollah Bashardoost, Afshin Darougheh, Marzieh Salehi, Ghorbanali Asadollahi · 2005 · DOAJ (DOAJ: Directory of Open Access Journals)
  82. Mood Stabilizers
    Keming Gao, David E. Kemp, Renrong Wu, Joseph R. Calabrese · 2015 · Wiley eBooks
  83. Pharmacological Treatment of Refractory Bipolar Disorder: What Does the Evidence Say?
    Konstantinos Ν. Fountoulakis · 2013 · Journal of Depression & Anxiety
  84. Revised psychopharmacological algorithms for the treatment of mood disorders in Japan
    Nobutaka Motohashi, Kunihiko Shioe, Jun Nakamura, Akihiko Ohshima, Kazuo Yamada, Hiroki Ozawa, Toshiyuki Someya, Yosuke Uchitomi, Teruhiko Higuchi · 2008 · International Journal of Psychiatry in Clinical Practice
  85. Biological Therapies
    Kostas N. Fountoulakis · 2014 · Springer eBooks
  86. Evidence Based Combination Therapy for Bipolar Disorder
    Stamatia Magiria, Melina Siamouli, Xénia Gonda, Apostolos Iacovides, Konstantinos Ν. Fountoulakis · 2012 · Springer eBooks
  87. Ventajas y desventajas del tratamiento de combinación con antipsicóticos. Reunión ECNP Consensus, marzo de 2008, Niza
    Guy M. Goodwin, Wolfgang Fleischhacker, Celso Arango, Pierre Baumann, Michael Davidson, Marc D. Binder, Peter Falkai, Shitij Kapur, Stefan Leucht, Rasmus Wentzer Licht et al. · 2011 · Psiquiatría Biológica
  88. Safety of carbamazepine extended-release capsules used in combination with other psychotropic medications for the treatment of bipolar I disorder.
    Richard H. Weisler, Amir H Kalali, Andrew J. Cutler, Thomas D Gazda, Lawrence D. Ginsberg · 2008 · PubMed Central
  89. Polypharmazie in der Behandlung bipolarer Störungen
    Heinz Grunze, Anna Forsthoff, Christoph Born · 2006 · Springer eBooks
  90. Neurobehavioural characteristics and relapse in addiction
    Henrietta Bowden‐Jones, Mike A. McPhillips, Eileen M. Joyce · 2006 · The British Journal of Psychiatry
  91. Lorazepam use during clinical trials of adults with bipolar mania episodes
    Daniel J. Safer · 2023 · Contemporary Clinical Trials Communications
  92. Use of gold/iron metal-organic framework nanoparticles (AuNPs/FeMOF)-modified glassy carbon electrode as an electrochemical sensor for the quantification of risperidone in patient plasma samples
    Zahra Golsanamlu, Haniyeh Pashanejad, Elaheh Rahimpour, Abolghasem Jouyban, Afsaneh Farjami, Jafar Soleymani, Fatemeh Ranjbar · 2025 · BMC Chemistry
  93. Atypical Antipsychotics for Bipolar Disorder: Overblown or Blown Over?
    Felicity Ng, Seetal Dodd, Michael Berk · 2007 · Deakin Research Online (Deakin University)
  94. Comparison of the Efficacy of Risperidone and Aripiprazole in Combination with Sodium Valproate in Patients with Acute Manic or Mixed Episodes
    Bahman Dieji, Ali Nazeri, Rezaie Omid, Akbar Biglarian, Nasir Amanat · 2017 · نشریه روان پرستاری
  95. Mood Stabilizers: Risperidone for Treating Bipolar Disorders in Adults
    Adriana Vasquez, William Victor Bobo · 2020 · Springer eBooks
  96. Treatment of Acute Mania
    Paul E. Holtzheimer, John F. Neumaier · 2003 · CNS Spectrums
  97. Rational Polypharmacy in Psychiatry
    S. Haque Nizamie, Sai Krishna Tikka · 2015 · InTech eBooks
  98. Treatment options for acute mania
    Pierre Thomas · 2003 · European Psychiatry
  99. Risperidone long-acting injection, a promising treatment for patients with bipolar disorder
    Luiz Dratcu, Dominiek Bamelis, Susan E. Libretto · 2005 · Journal of Mental Health
  100. Traitement du trouble bipolaire en phase maniaque : synthèse critique des recommandations internationales Treatment of manic phases of bipolar disorder: Critical synthesis of international guidelines
    H. Mondor A. Chenevier · 2014